Find a Trial Find Expert Physicians 
News Trial Stats
Clinical TrialsFacts & Fears Who pays for it, placebos, being a guinea pig, and what taking part really means.Basics ofTheranostics A fundamental way of finding and treating your cancer, all in one.Basics ofRadiation What is radiation, and how can it benefit you? InterpretingYour Scans What CT, MRI and PET can and can’t tell you about cancer.What to Expect as aTheranostic Patient Scans, treatment day, and the precautions once you are home.Basics ofDosimetry How much radiation each organ and tumor actually absorbs.TheranosticDictionary Plain-language meanings for the vocabulary on your paperwork.
News Trial Stats
Contact XCancer®
Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT07249892
A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases
Overview
A multicenter, open-label Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, dosimetry and efficacy of BPR-6023021 in subjects with advanced solid tumors with bone metastases
Sponsor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase
Phase 1/2
Contacts
Ruofei Tong (CONTACT)
ruofei.tong@btyy.com
+86-18002098164
Wei Fan (PRINCIPAL_INVESTIGATOR)
Rui Dong (CONTACT)
rui.dong@btyy.com
+8613158775185
Yan Yang (STUDY_DIRECTOR)
ClinicalTrials.gov
NCT07249892Share your feedback
Help us improve your experience